Skip to content

Clinical trials

Phase 3 Hepatitis C trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C Phase: Phase 3 Country / region: Canada Clear all

56 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20062
20073
20082
20091
20101
201111
20128
20133
20146
20156
20163
20177
20181
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed48
Terminated6
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences12
Bristol-Myers Squibb9
AbbVie7
Janssen R&D Ireland5
GlaxoSmithKline4
Debiopharm International SA3
Boehringer Ingelheim2
Human Genome Sciences Inc.2
Janssen Infectious Diseases BVBA2
Vertex Pharmaceuticals Incorporated2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C56
Hepatitis C, Chronic14
Fibrosis7
Hepatitis4
Bronchiolitis Obliterans Syndrome3
Acquired Immunodeficiency Syndrome2
HIV Infections2
Liver Diseases2
Thrombocytopenia2
Hepatitis B1

Trials

Showing 1 to 25 of 56. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.